BCMO
NVO

Buckingham Capital Management (Ohio)’s Novo Nordisk NVO Stock Holding History

Buckingham Capital Management (Ohio)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$5.51M Buy
64,078
+31,543
+97% +$3.41M 0.63% 38
2024
Q3 		$3.87M Buy
+32,535
New +$4.34M 0.44% 48

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Buckingham Capital Management (Ohio)'s NVO Position: Q4 2024 in Review

Buckingham Capital Management (Ohio) increased its Novo Nordisk (NVO) stake by 97% in Q4 2024, buying an estimated $3.41M and bringing the position to 64,078 shares worth $5.51M. The position accounts for 0.63% of the portfolio, ranked #38.

Buckingham Capital Management (Ohio) first reported a position in NVO in Q3 2024 and has held it in 2 quarters since. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Buckingham Capital Management (Ohio) held 64,078 shares of Novo Nordisk worth $5.51M as of Q4 2024.
  • Buckingham Capital Management (Ohio) bought 31,543 Novo Nordisk shares in Q4 2024, an estimated $3.41M.
  • Novo Nordisk made up 0.63% of Buckingham Capital Management (Ohio)'s portfolio in Q4 2024, its #38 holding.
  • Buckingham Capital Management (Ohio) first reported a position in Novo Nordisk in Q3 2024 and has held it in 2 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Buckingham Capital Management (Ohio)'s 13F filing for Q4 2024, filed 31 Jan 2025.